News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Manni Mohyuddin: It is often well known that the control arm is inferior prior to a single patient being enrolled on trial!
Photo taken from Manni Mohyuddin/X
Jan 30, 2024, 15:51

Manni Mohyuddin: It is often well known that the control arm is inferior prior to a single patient being enrolled on trial!

Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute, University of Utah, shared on X/Twitter:

“A common excuse for poor control arms is that they were valid at the time the trial enrolled. We have shown in The Lancet Haematology, that it is often well known that the control arm is inferior prior to a single patient being enrolled on trial!”

Image

View more information.
Source: Manni Mohyuddin/X

cancer clinical trials Manni Mohyuddin OncoDaily Oncology patient involvement in trials poor control arms The Lancet Haematology
Special Coverage
Blog
Nov 13, 2024, 09:09
Yüksel Ürün: Not all that shines is Prostate cancer – a striking reminder from Daniela Oprea-Lager
Blog
Nov 13, 2024, 09:01
Updated Results with Mitazalimab as a first-line treatment for advance pancreatic cancer
Blog
Nov 13, 2024, 08:59
Miriam Mutebi: What To Expect During A Mammogram
Insight
Nov 13, 2024, 08:56
Rachel Riechelmann: Low dose Everolimus for patients with Neuroendocrine tumors
Insight
Nov 13, 2024, 08:51
Reporting pharmacogenetic variants and cancer WGS data could guide safer prescribing
Blog
Nov 13, 2024, 08:49
Yüksel Ürün: Promising findings on SGLT2 as a biomarker for papillary RCC by Erman Akkus
Blog
Nov 13, 2024, 08:46
Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer
Blog
Nov 13, 2024, 08:39
Eva Blondeaux on safety of pregnancy in BRCA carriers
Blog
Nov 13, 2024, 08:39
What can cancer in ferrets, opossums, and even penguins teach us about cancer in humans - AACR
Blog
Nov 13, 2024, 08:36
Research Is The Reason Nicole Seagriff had options to treat her breast cancer - The Breast Cancer Research Foundation
Blog
Nov 13, 2024, 08:30
Patrick Hwu: Exploring the unique partnership between Moffitt Cancer Center and Iovance Biotherapeutics
Insight
Nov 13, 2024, 08:27
Paolo Tarantino: The promise and challenges of response-adapted trials in breast oncology